Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 09, 2025

Get In Touch

Emerging Treatment Helps Reverse Chronic Heart Failure: Circulation Study Cardiology and CTVS

Emerging Treatment Helps Reverse Chronic Heart Failure: Circulation Study

  • 24 July 2025
  • 3 months ago

CIMT May Predict Risk Of New-Onset Diabetes And Diabetic Neuropathy, Finds Study Diabetes and Endocrinology

CIMT May Predict Risk Of New-Onset Diabetes And Diabetic Neuropathy, Finds Study

  • 24 July 2025
  • 3 months ago

Optimal Blood Pressure Maintenances Delays Ageing Of Brain: Study Cardiology and CTVS

Optimal Blood Pressure Maintenances Delays Ageing Of Brain: Study

  • 24 July 2025
  • 3 months ago

APPLE Watch Picks-Up Epsilon Waves Of ARVD, An EHJ Case Report. Cardiology and CTVS

APPLE Watch Picks-Up Epsilon Waves Of ARVD, An EHJ Case Report.

  • 24 July 2025
  • 3 months ago

Include COVID History In Screening Prior To Non Cardiac Elective Surgeries: JAMA Surgery

Include COVID History In Screening Prior To Non Cardiac Elective Surgeries: JAMA

  • 24 July 2025
  • 3 months ago

FDA Expands Approval Of Valsartan For Hypertension For Children Below 5 Years Pediatrics and Neonatology

FDA Expands Approval Of Valsartan For Hypertension For Children Below 5 Years

  • 24 July 2025
  • 3 months ago

Remote Programming Of Cardiac Implantable Devices Safe For MRI Scan Radiology

Remote Programming Of Cardiac Implantable Devices Safe For MRI Scan

  • 24 July 2025
  • 3 months ago

New PCSK9 Inhibitor Halves LDL With 3 Monthly Dosing: AHA 2023 Cardiology and CTVS

New PCSK9 Inhibitor Halves LDL With 3 Monthly Dosing: AHA 2023

  • 24 July 2025
  • 3 months ago

Sacubitril/Valsartan Decreases Plasma NT-ProBNP In HF Patients With Preserved Ejection Fraction: JAMA Cardiology and CTVS

Sacubitril/Valsartan Decreases Plasma NT-ProBNP In HF Patients With Preserved Ejection Fraction: JAMA

  • 24 July 2025
  • 3 months ago

Dual Defibrillator Pad Effective In Treating Atrial Fibrillation In Obese Patients: JAMA Cardiology and CTVS

Dual Defibrillator Pad Effective In Treating Atrial Fibrillation In Obese Patients: JAMA

  • 24 July 2025
  • 3 months ago

Recent News

Maha CET Cell extends NEET PG Counselling registra...

  • 09 November, 2025

HC relief to 80-year-old doctor, pension benefits...

  • 09 November, 2025

VACANCIES For SR Post At ESIC Medical College & Ho...

  • 09 November, 2025

Tamil Nadu to Mandate National Formulary Subscript...

  • 09 November, 2025

Emergency hysterectomy in Placenta praevia grade I...

  • 09 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.